首页> 美国卫生研究院文献>Pharmaceuticals >Electroconvulsive Therapy and Age: Effectiveness Safety and Tolerability in the Treatment of Major Depression among Patients under and over 65 Years of Age

【2h】

Electroconvulsive Therapy and Age: Effectiveness Safety and Tolerability in the Treatment of Major Depression among Patients under and over 65 Years of Age

机译：电耦合治疗和年龄：在65岁以下患者治疗主要抑郁症的有效性安全性和耐受性

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

期刊名称 Pharmaceuticals
作者
Monika Dominiak; Anna Z. Antosik-Wójcińska; Marcin Wojnar; Paweł Mierzejewski;
展开▼
作者单位

展开▼
年(卷),期 2021(14),6
年度 2021
页码 582
总页数 11
原文格式 PDF
正文语种
中图分类药学;
关键词

机译：电谐波治疗;重大抑郁;治疗抗抑郁;老年人;认知功能;自传记忆;

相似文献

外文文献
中文文献
专利

1. A Bayesian framework systematic review and meta-analysis of anesthetic agents effectiveness/tolerability profile in electroconvulsive therapy for major depression [J] . Guillaume Fond, Djamila Bennabi, Emmanuel Haffen, Scientific reports. . 2016,第期

机译：贝叶斯框架系统综述和麻醉剂效果/可耐受性剖面的荟萃分析，用于重大抑郁症
2. Safety, Tolerability and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy in Patients Aged = 65 Years with Focal Seizures [J] . Costa Raquel, Steinhoff Bernhard, Gama Helena, Drugs and aging . 2018,第12期

机译：Eslicarbazepine醋酸盐作为患者患者辅助治疗的安全性，耐受性和疗效; = 65年焦点癫痫发作
3. Long-term safety and tolerability of saxagliptin add-on therapy in older patients (aged ≥65 years) with type 2 diabetes [J] . Nayyar Iqbal, Elsie Allen, Peter ?hman Clinical Interventions in Aging . 2014,第2期

机译：沙格列汀联合治疗对2型糖尿病老年患者（≥65岁）的长期安全性和耐受性
4. Therapy of Patients with Chronic Immune Thrombocytopenic Purpura (ITP): Efficacy, Tolerability, and Safety of a New Nanofiltered Intravenous Immunoglobulin [C] . H.-H. Wolf, S. Davies, G. Smith, European Haematology Association . 2002

机译：慢性免疫血小板减少症患者的治疗患者（ITP）：一种新的纳米过滤静脉内免疫球蛋白的疗效，耐受性和安全性
5. The Effects of Reducing Depressive Severity in Adult Patients Ages 18-65 Diagnosed with Major Depressive Disorder Utilizing Electronic 9-Item Patient Health Questionnaire (PHQ-9) [D] . Okorom, Charles. 2021

机译：减少抑郁严重程度在18-65岁的成人患者中诊断患有电子9项患者健康问卷（PHQ-9）的抑郁症患者
6. A Bayesian framework systematic review and meta-analysis of anesthetic agents effectiveness/tolerability profile in electroconvulsive therapy for major depression [O] . Guillaume Fond, Djamila Bennabi, Emmanuel Haffen, -1

机译：贝叶斯框架对大抑郁症电惊厥治疗中麻醉剂有效性/耐受性的系统评价和荟萃分析
7. Electroconvulsive Therapy and Age: Effectiveness, Safety and Tolerability in the Treatment of Major Depression among Patients under and over 65 Years of Age [O] . Monika Dominiak, Anna Z. Antosik-Wójcińska, Marcin Wojnar, 2021

机译：电耦合治疗和年龄：在65岁以下患者治疗主要抑郁症的有效性，安全性和耐受性

Electroconvulsive Therapy and Age: Effectiveness Safety and Tolerability in the Treatment of Major Depression among Patients under and over 65 Years of Age

著录项

相似文献

相关主题

期刊订阅